Eric Faulkner

Insider Reports History

Location: Houston, TX
Signature: /s/ Christopher Downs, Attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Faulkner:

Form 4 holding Chief Technology Officer

CNS Pharmaceuticals, Inc.

Security class: Restricted Stock Units
Shares / value: 9,500
Estimated value
Report date: 02 Mar 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Eric Faulkner

4 CNSP

CNS Pharmaceuticals, Inc.

Report period: 02 Mar 2026
Transactions: 1
Transaction value: $0
Filing time: 04 Mar 2026, 17:02
Role: Chief Technology Officer
Next action: Open filing details

3 CNSP

CNS Pharmaceuticals, Inc.

Report period: 02 Mar 2026
Transactions: 0
Transaction value: $0
Filing time: 04 Mar 2026, 17:02
Role: Chief Technology Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .